Proposed legislation may seriously restrict access to compounded medication.

Learn more and take action: http://ProtectMyCompounds.com/

The Senate HELP Committee has proposed a Bill called the "Pharmaceutical Compounding Quality and Accountability Act" or Senate Bill 959 (S.959), which has significant implications for the Autism Spectrum Disorder (ASD) community and may restrict access to compounded medications you have come to rely on.

If enacted, sterile compounds may be difficult or even impossible to obtain such as;
• Glutathione
• Methyl B12

Non-sterile personalization of medications which make prescriptions easier for your child to take may be harder to get such as;
• capsules and tablets made without allergy inducing fillers or excipients
• creams
• liquid forms

The Bill is a reaction to the tragedy at the New England Compounding Center (NECC) who produced contaminated injectable medication which resulted in patient deaths and others contracting meningitis. Safety is of the utmost importance and the attempt to address this tragedy should be applauded.

Bill S. 959 could limit your Physicians and Pharmacists ability to provide you with the solutions your child needs.

Under the provisions of S.959 could
• force Compounding Pharmacies to give up sterile compounding, or to limit sales within the states in which they are located
• give the Food and Drug Administration (FDA) extensive power making it much harder for your doctor to modify medications to meet the specific needs of ASD patients.
• give FDA further authority to require doctors to provide justification and documentation before they can authorize the formulations ASD patients need and the authority to make it harder or even possibly delaying or denying treatment for your children.

Please visit http://protectmycompounds.com/ for more information and to contact your Senators and Representatives to voice your opposition to S.959.